Aurobindo Pharma's Unit-VI completes USFDA inspection
(28 Aug 2026)

Back
Aurobindo Pharma announced that United States Food and Drug Administration (US FDA) inspected Unit-VI, an API manufacturing facility of Apitoria Pharma, a wholly owned subsidiary of the Company, situated at E-Bonangi Village, Parawada Mandal, Anakapalli District, 531019, Andhra Pradesh from 24 August to 28 August 2026. The inspection concluded with three observations, which are procedural in nature.

Copyright © 2026 Arihant Capital Markets Ltd. All rights Reserved.

Designed, Developed and Content powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

x
  • QR-CodeNew